[1]
Iacovelli, R., Cartenì, G., Milella, M., Berardi, R., Di Lorenzo, G., Verzoni, E., Rizzo, M., Santoni, M. and Procopio, G. 2014. Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib. Canadian Urological Association Journal. 8, 3-4 (Mar. 2014), e121–5. DOI:https://doi.org/10.5489/cuaj.1604.